Butylphthalide improved outcomes in more than half of patients with ischemic stroke

Butylphthalide improved 90-day clinical outcomes in those with acute ischemic stroke who also received IV recombinant tissue plasminogen activator and/or endovascular treatment, per research presented at International Stroke Conference.“The medication was given to patients with acute ischemic stroke who were also receiving treatment to restore blood flow to the brain,” Baixue Jia, MD,

Related Keywords

Dallas ,Texas ,United States ,Byrobert Herpen ,Heather Biele ,Baixue Jia ,International Stroke Conference ,Tiantan Hospital Of Capital Medical University ,Robert Herpen ,Beijing Tiantan ,International Stroke ,Beijing Tiantan Hospital ,Capital Medical University ,Rankin Scale ,